Targeted therapeutic vaccine against Pglycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers

Details for Australian Patent Application No. 2004262472 (hide)

International Classifications

Event Publications

16 February 2006 PCT application entered the National Phase

PCT publication WO2005/014036 Priority application(s): WO2005/014036

16 March 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 25 Jan 2006

13 July 2006 Assignment before Grant

AC Immune S.A.; Universite de Reims The application has been assigned to AC Immune S.A. Assignments before Grant, Section 113

14 July 2011 Application Accepted

Published as AU-B-2004262472

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.